CIRCULATING MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (MIP1-A) AS A POTENTIAL BIOMARKER FOR THE DIAGNOSIS OF PATIENTS WITH PANCREATIC ADENOCARCINOMA

Karabulut S., Afsar C. U., KARABULUT M., ALIS H., BINBOGA S., OZKARA I. O., ...More

ACTA MEDICA MEDITERRANEA, vol.32, no.4, pp.1035-1040, 2016 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 32 Issue: 4
  • Publication Date: 2016
  • Doi Number: 10.19193/0393-6384_2016_4_128
  • Journal Name: ACTA MEDICA MEDITERRANEA
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1035-1040
  • Çukurova University Affiliated: No

Abstract

Introduction: Pancreatic cancer is the fourth leading cause of cancer-related death in the United States among both men and women. Macrophage inflammatory protein-1 alpha [MIP-1 alpha/CC-chemokine ligand 3 (CCL3)] is a small chemotactic protein detected in several kinds of tumor tissue samples and functions as a key regulator of cancer progression. This study aimed to investigate the serum MIP-1 alpha/CCL3 levels in pacreatic adenocarcinoma (PA).